Tag: preclinical
-
Duchenne Gene-Editing Company Launched, Raising $5M
A biotechnology start-up is applying a process for editing-out disease-causing mutations to correct the inherited disorder Duchenne muscular dystrophy.
-
Patent Issued for Peptides in Diabetes Gene Therapy
A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure.
-
Stomach Acid Harnessed to Power Ingestible Devices
Researchers at MIT and Harvard University designed a tiny device that in tests with animals show it can run for days powered by acids in the stomach.
-
EU Project to Develop More Versatile Heart Pacemakers
An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions.
-
Biopharm, Hospital to Partner on Cell Energy Diseases
A biopharmaceutical company in Sweden and children’s hospital in the U.S. are collaborating on research into deficiencies in cells’ energy components responsible for a number of genetic disorders.
-
Safer Engineered-Cell Cancer Immunotherapy Designed
A biotechnology company designed a new type of engineered T-cell from the immune system that more precisely targets tumors and stays away from healthy cells.
-
Electronic Gene Editing Corrects Inherited Blood Disorder
A team at National Institutes of Health used an electronic-aided process to carry out a gene editing technique that in lab mice repaired a genetic defect causing a rare blood disease.
-
Sanofi Licensing Antibody for Autoimmune Diseases
The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College.
-
Stem Cells Shown to Regenerate Dental Pulp Tissue
A combination of dental pulp stem cells and cells from human umbilical cords, mixed with a common hydrogel, were shown in lab rats to regenerate pulp-like tissue in teeth roots.
-
Peptide-Infused Gel Shown to Heal Chronic Wounds
A tissue engineering group developed a gel material infused with a synthetic peptide that in lab cultures and animals healed chronic diabetic wounds faster than a current commercial treatment.